98%
921
2 minutes
20
Pulmonary Sclerosing Pneumocytoma (PSP) represents a rare benign tumor that exhibits a predisposition towards females. Often asymptomatic, its identification usually occurs incidentally through imaging modalities. Histologically, PSP demonstrates features consistent with pneumocytic differentiation and possesses a dual-cell population. However, in rare instances it may demonstrate pleural invasion or lymph node metastasis. Diagnosing PSP through small biopsy or frozen section presents considerable challenges attributed to its heterogeneous growth patterns and striking similarity to well-differentiated pulmonary adenocarcinoma. We report a case of PSP in a 57-year-old female smoker, presenting as a slow-growing 2.5 cm mass that recently exhibited enlargement, as noted on computed tomography (CT) scan. The recommendation for excising the mass prompted the patient to undergo a right robotic-assisted thoracoscopic procedure, which entailed wedge resection of the right lower lobe and an intraoperative consultation. A completion right lower lobectomy was performed, accompanied by lymph node dissection, following a frozen section diagnosis indicating at least adenocarcinoma in situ. The permanent section revealed bland cuboidal cells lining papillary and sclerotic areas, with occasional atypical features such as prominent nucleoli and scattered mitotic figures. Adjacent foci of atypical adenomatous hyperplasia (AAH) were noted. Immunohistochemical (IHC) staining revealed positive Napsin A, keratin AE1/3, and CK7 in surface cells but not in round cells. Both EMA and TTF1 immunostains highlighted surface cells and scattered round cells. Elastic stain highlighted visceral pleural involvement. The combined morphology and immunoprofile supported the diagnosis of PSP. This case underscores the critical importance of accurately diagnosing slow-growing pulmonary nodules, which are increasingly detected by the widespread use of imaging for various medical conditions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236615 | PMC |
http://dx.doi.org/10.62347/KLWT4935 | DOI Listing |
Front Oncol
July 2025
Department of Pathology, 920th Hospital of the Joint Logistics Support Force of Chinese People's Liberation Army, Kunming, Yunnan, China.
Background: Bronchiolar adenoma/ciliated muconodular papillary tumor (BA/CMPT) is a rare benign pulmonary tumor from the bronchiolar epithelium. Histologically, it features a continuous basal cell layer and luminal cells. Its resemblance to invasive mucinous adenocarcinoma (IMA) and acinar adenocarcinoma complicates intraoperative frozen section diagnosis.
View Article and Find Full Text PDFClin Nucl Med
July 2025
Department of Nuclear Medicine, University of Health Sciences, Ankara Training and Research Hospital.
Primary pulmonary sclerosing pneumocytoma (PsP) is an unusual benign pulmonary tumor with low malignant potential. Clinical presentation may sometimes imitate more serious conditions. We described a case of newly diagnosed prostate cancer with a PSMA-avid, well-circumscribed lesion in the right lung in 68Ga PSMA PET-CT, initially mimicking a metastatic lesion.
View Article and Find Full Text PDFThorac Cancer
July 2025
Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Background: This study evaluated the presentation of pulmonary sclerosing pneumocytoma (PSP) in F-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT) with the aim of increasing awareness of the disease.
Methods: Retrospective analysis was performed on 46 PSP patients who had F-FDG PET/CT before surgery or pathological examination from January 2011 to December 2023. The F-FDG PET/CT manifestations of PSP were summarized, and the correlation between the maximum diameter of the tumor and PET metabolic parameters was analyzed, including the maximum standardized uptake value (SUV), the mean SUV (SUV), the peak SUV (SUV), metabolic tumor volume (MTV) and total lesion glycolysis (TLG).
Clin Lung Cancer
June 2025
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA.
Cureus
April 2025
Division of Pulmonary Medicine, Cooper University Hospital, Camden, USA.
Pulmonary sclerosing pneumocytomas are rare benign tumors, with some cases demonstrating potential for aggressive metastasis. Patients typically are asymptomatic with a nodule/mass seen on incidental imaging; however, they can present with nonspecific symptoms such as cough, shortness of breath, and chest pain. Diagnosis can only be confirmed with biopsy, and computed tomography-guided or fluoroscopy-guided needle biopsies are routinely used.
View Article and Find Full Text PDF